STOCKHOLM, March 23, 2026 /PRNewswire/ -- BioArctic's AB (publ) (STOCKHOLM: BIOA B ) partner Eisai presented new data at the 2026 International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders (AD/PD™), held in Copenhagen, Denmark March 17-21....
Hence then, the article about new data on long term real world treatment with lecanemab presented at the 2026 ad pd congress was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( New data on long-term, real-world treatment with lecanemab presented at the 2026 AD/PD™ congress )
Also on site :
- Macy’s ‘Plush’ 5-Piece Comforter Set Has ‘Pretty’ Embroidery and 2 Matching Throw Pillows for Just $60
- Fans Are Furious With Wendy’s After the Fast Food Chain Is Seemingly Caught ‘Lying’
- In 1912, a Manhattan factory sold a cream-filled chocolate cookie to a single grocer in New Jersey; decades later, over 500 billion Oreos have been sold